Your browser doesn't support javascript.
loading
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.
Judd, Julia; Abdel Karim, Nagla; Khan, Hina; Naqash, Abdul Rafeh; Baca, Yasmine; Xiu, Joanne; VanderWalde, Ari M; Mamdani, Hirva; Raez, Luis E; Nagasaka, Misako; Pai, Sachin Gopalkrishna; Socinski, Mark A; Nieva, Jorge J; Kim, Chul; Wozniak, Antoinette J; Ikpeazu, Chukwuemeka; de Lima Lopes, Gilberto; Spira, Alexander I; Korn, W Michael; Kim, Edward S; Liu, Stephen V; Borghaei, Hossein.
Afiliación
  • Judd J; Department of Hematology-Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.
  • Abdel Karim N; Department of Hematology-Oncology, Augusta University-Medical College of Georgia, Georgia Cancer Center, Augusta, Georgia.
  • Khan H; Department of Hematology-Oncology, The Warren Alpert Medical School, Brown University, Providence, Rhode Isand.
  • Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Baca Y; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma.
  • Xiu J; Caris Life Sciences, Phoenix, Arizona.
  • VanderWalde AM; Caris Life Sciences, Phoenix, Arizona.
  • Mamdani H; Department of Medical Oncology, West Cancer Center and Research Institute, Memphis, Tennessee.
  • Raez LE; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan.
  • Nagasaka M; Department of Hematology-Oncology, Memorial Cancer Institute/Memorial Health Care System/Florida International University, Hollywood, Florida.
  • Pai SG; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan.
  • Socinski MA; Department of Medical Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama.
  • Nieva JJ; Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, Florida.
  • Kim C; Department of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Wozniak AJ; Department of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Ikpeazu C; Department of Medical Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • de Lima Lopes G; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami and the Miller School of Medicine, Miami, Florida.
  • Spira AI; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami and the Miller School of Medicine, Miami, Florida.
  • Korn WM; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology Research, Fairfax, Virginia.
  • Kim ES; Caris Life Sciences, Phoenix, Arizona.
  • Liu SV; Department of Medical Oncology, City of Hope, Los Angeles, California.
  • Borghaei H; Department of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
Mol Cancer Ther ; 20(12): 2577-2584, 2021 12.
Article en En | MEDLINE | ID: mdl-34518295

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Secuenciación de Nucleótidos de Alto Rendimiento / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Secuenciación de Nucleótidos de Alto Rendimiento / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article